assertion

Full identifier: http://purl.org/np/RAncfbAc0z2feYTdgozXpkJ6Ozbuc2fRX28jUgZdOHJtY#assertion

Searching for classes... Loading...

Searching for instances... Loading...

Minted in Nanopublication

 RAncfbAc0z comment approve/disapprove edit as derived nanopublication

This is a local identifier minted within the nanopublication. http://purl.org/np/RAncfbAc0z...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAncfbAc0z... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAncfbAc0z...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Elif Ozkan
2022-10-13T13:16:28.034Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
2022-10-13T13:16:28.034108
Elif Ozkan
2022-10-13T13:16:28.034Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
methylclothiazide is indicated For use in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Also used as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Also. used as. adjunction therapy in. edema linked to congestive. heart failure and liver failure.
Elif Ozkan
2022-10-13T13:16:28.034Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)